vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and Orange County Bancorp, Inc. (OBT). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $33.0M, roughly 1.2× Orange County Bancorp, Inc.). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs 24.7%, a 13.0% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 20.6%). Orange County Bancorp, Inc. produced more free cash flow last quarter ($41.3M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 14.3%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.

CDXS vs OBT — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.2× larger
CDXS
$38.9M
$33.0M
OBT
Growing faster (revenue YoY)
CDXS
CDXS
+60.7% gap
CDXS
81.3%
20.6%
OBT
Higher net margin
OBT
OBT
13.0% more per $
OBT
37.6%
24.7%
CDXS
More free cash flow
OBT
OBT
$21.8M more FCF
OBT
$41.3M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
14.3%
OBT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
OBT
OBT
Revenue
$38.9M
$33.0M
Net Profit
$9.6M
$12.4M
Gross Margin
94.8%
Operating Margin
27.1%
41.4%
Net Margin
24.7%
37.6%
Revenue YoY
81.3%
20.6%
Net Profit YoY
192.5%
73.5%
EPS (diluted)
$0.13
$0.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
OBT
OBT
Q4 25
$38.9M
$33.0M
Q3 25
$8.6M
$33.7M
Q2 25
$15.3M
$32.5M
Q1 25
$7.5M
$28.0M
Q4 24
$21.5M
$27.4M
Q3 24
$12.8M
$27.1M
Q2 24
$8.0M
$27.9M
Q1 24
$17.1M
$25.3M
Net Profit
CDXS
CDXS
OBT
OBT
Q4 25
$9.6M
$12.4M
Q3 25
$-19.6M
$10.0M
Q2 25
$-13.3M
$10.5M
Q1 25
$-20.7M
$8.7M
Q4 24
$-10.4M
$7.2M
Q3 24
$-20.6M
$3.2M
Q2 24
$-22.8M
$8.2M
Q1 24
$-11.5M
$9.3M
Gross Margin
CDXS
CDXS
OBT
OBT
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
OBT
OBT
Q4 25
27.1%
41.4%
Q3 25
-220.3%
38.6%
Q2 25
-83.9%
41.9%
Q1 25
-271.6%
40.3%
Q4 24
-34.2%
32.8%
Q3 24
-129.0%
14.8%
Q2 24
-284.9%
36.6%
Q1 24
-69.6%
45.9%
Net Margin
CDXS
CDXS
OBT
OBT
Q4 25
24.7%
37.6%
Q3 25
-228.1%
29.7%
Q2 25
-86.6%
32.2%
Q1 25
-274.3%
31.1%
Q4 24
-48.4%
26.2%
Q3 24
-160.8%
11.8%
Q2 24
-285.2%
29.4%
Q1 24
-67.4%
36.7%
EPS (diluted)
CDXS
CDXS
OBT
OBT
Q4 25
$0.13
$0.94
Q3 25
$-0.22
$0.75
Q2 25
$-0.16
$0.87
Q1 25
$-0.25
$0.77
Q4 24
$-0.12
$0.64
Q3 24
$-0.29
$0.28
Q2 24
$-0.32
$0.73
Q1 24
$-0.16
$0.82

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
OBT
OBT
Cash + ST InvestmentsLiquidity on hand
$78.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$284.4M
Total Assets
$147.8M
$2.7B
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
OBT
OBT
Q4 25
$78.2M
Q3 25
$58.7M
Q2 25
$66.3M
Q1 25
$59.8M
Q4 24
$73.5M
Q3 24
$90.3M
Q2 24
$73.2M
Q1 24
$85.5M
Total Debt
CDXS
CDXS
OBT
OBT
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
OBT
OBT
Q4 25
$50.5M
$284.4M
Q3 25
$38.5M
$270.1M
Q2 25
$55.6M
$252.6M
Q1 25
$49.6M
$201.3M
Q4 24
$66.9M
$185.5M
Q3 24
$73.4M
$193.1M
Q2 24
$61.4M
$177.5M
Q1 24
$79.3M
$168.7M
Total Assets
CDXS
CDXS
OBT
OBT
Q4 25
$147.8M
$2.7B
Q3 25
$124.0M
$2.6B
Q2 25
$138.2M
$2.6B
Q1 25
$128.9M
$2.6B
Q4 24
$149.0M
$2.5B
Q3 24
$148.2M
$2.5B
Q2 24
$132.0M
$2.5B
Q1 24
$149.6M
$2.5B
Debt / Equity
CDXS
CDXS
OBT
OBT
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
OBT
OBT
Operating Cash FlowLast quarter
$20.1M
$43.8M
Free Cash FlowOCF − Capex
$19.6M
$41.3M
FCF MarginFCF / Revenue
50.3%
125.1%
Capex IntensityCapex / Revenue
1.3%
7.6%
Cash ConversionOCF / Net Profit
2.09×
3.53×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$69.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
OBT
OBT
Q4 25
$20.1M
$43.8M
Q3 25
$-7.7M
$30.2M
Q2 25
$-18.0M
$-5.0M
Q1 25
$-13.8M
$4.8M
Q4 24
$-16.5M
$34.6M
Q3 24
$-13.0M
$10.2M
Q2 24
$-12.2M
$9.3M
Q1 24
$-7.8M
$2.3M
Free Cash Flow
CDXS
CDXS
OBT
OBT
Q4 25
$19.6M
$41.3M
Q3 25
$-7.9M
$29.6M
Q2 25
$-20.5M
$-5.7M
Q1 25
$-15.1M
$4.3M
Q4 24
$-18.2M
$32.9M
Q3 24
$-14.0M
$10.0M
Q2 24
$-12.6M
$9.2M
Q1 24
$-8.9M
$2.0M
FCF Margin
CDXS
CDXS
OBT
OBT
Q4 25
50.3%
125.1%
Q3 25
-91.7%
87.8%
Q2 25
-133.6%
-17.5%
Q1 25
-199.6%
15.5%
Q4 24
-85.0%
120.0%
Q3 24
-109.0%
36.7%
Q2 24
-157.5%
32.8%
Q1 24
-52.2%
7.9%
Capex Intensity
CDXS
CDXS
OBT
OBT
Q4 25
1.3%
7.6%
Q3 25
2.1%
1.8%
Q2 25
16.4%
2.3%
Q1 25
16.7%
1.8%
Q4 24
8.3%
6.3%
Q3 24
7.8%
1.1%
Q2 24
5.0%
0.4%
Q1 24
6.6%
1.0%
Cash Conversion
CDXS
CDXS
OBT
OBT
Q4 25
2.09×
3.53×
Q3 25
3.01×
Q2 25
-0.47×
Q1 25
0.56×
Q4 24
4.83×
Q3 24
3.19×
Q2 24
1.13×
Q1 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons